Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents? Nakagawa R, Iwamoto H, Naito R, Kadomoto S, et al. Anticancer Res 2023;43:1351-1359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakagawa R, Iwamoto H, Naito R, Kadomoto S, et al. Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents? Anticancer Res 2023;43:1351-1359.
PMID: 36854500